CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
CHINA PHARMA HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.69−0.02 (-3.49%)
Close on Oct 19, 2026
- Market cap
- $27.76M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q4 FY2016 Ended Dec 31, 2016 | Mar 31, 2017 | Before market open | – | – | – |
Press releases
Announcements China Pharma filed with the SEC
PRESS RELEASE DATED AS OF JULY 22, 2026
Material agreement · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED APRIL 4, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE, DATED FEBRUARY 23, 2024.
Regulation FD disclosure · EX-99.1 to Form 8-K